Ellagic Acid

The Global Nutrition Network brings to you possibly the breakthrough of the century in the search for the prevention of cancer.

Chances are that you know someone with cancer - it may even be a family member. Studied since 1993 at the Hollings Cancer Center in the Medical University of South Carolina (MUSC), clinical tests show that Ellagic Acid, a naturally occurring plant phenol found in the highest concentrations in red raspberries, may be the most potent way to prevent cancer, inhibit the growth of cancer cells, and arrest the growth of cancer in persons with a genetic predisposition for cancer.

Dr. Daniel Nixon, president of the American Health Foundation, and his colleagues have studied Ellagic Acid since 1993 at MUSC. His recently published results show:

• Cervical cells predisposed to the Human Papilloma Virus when exposed to Ellagic Acid from red raspberries experienced apoptosis (normal cell death).
• Ellagic Acid stops cancer cells from dividing (a process called mitosis).
• Ellagic Acid will not allow cancer cells to destroy the P53 gene, which safeguards cervical cells from turning cancerous.

Similar test results were obtained in breast, prostate, pancreatic, esophageal, skin and colon cancer. For a copy of the booklet, "The Seed of Hope" and an audio tape by Dr. David Gangemi who was Director of research at the Medical University of South Carolina from 1992 to 1999 call 1-800-499-9112

Published Results Show Similar Results in The Following:

• Breast Cancer
• Prostate Cancer
• Pancreatic Cancer
• Esophageal Cancer
• Skin Cancer
• Colon Cancer

Added Benefits of All Natural Ellagic Acid may include:

• Antiviral
• Antibacterial
• Promotes wound healing
• Reduces heart disease
• Reduces and reverses Liver Fibrosis
• Lowers incidence of birth defects
• No negative side effects
• No danger of overdose

" With all of the data now emerging to support the cancer/diet relationship, why has it taken the medical community so long to accept and appreciate the connection between diet and cancer?" Dr. David Gangemi, Hollings Cancer Center